别名 白细胞介素-12亚单位p40、CLMF、CLMF p40 + [17] |
简介 Cytokine that can act as a growth factor for activated T and NK cells, enhance the lytic activity of NK/lymphokine-activated killer cells, and stimulate the production of IFN-gamma by resting PBMC.
Associates with IL23A to form the IL-23 interleukin, a heterodimeric cytokine which functions in innate and adaptive immunity. IL-23 may constitute with IL-17 an acute response to infection in peripheral tissues. IL-23 binds to a heterodimeric receptor complex composed of IL12RB1 and IL23R, activates the Jak-Stat signaling cascade, stimulates memory rather than naive T-cells and promotes production of pro-inflammatory cytokines. IL-23 induces autoimmune inflammation and thus may be responsible for autoimmune inflammatory diseases and may be important for tumorigenesis. |
作用机制 IL-12p40抑制剂 [+1] |
在研机构 |
原研机构 |
非在研适应症- |
最高研发阶段申请上市 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
作用机制 IL-12p40抑制剂 [+1] |
在研机构 |
原研机构 |
在研适应症 |
非在研适应症- |
最高研发阶段临床1期 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
靶点- |
作用机制 IL-12p40抑制剂 [+1] |
在研机构 |
原研机构 |
在研适应症 |
非在研适应症- |
最高研发阶段临床前 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
开始日期2022-10-17 |
申办/合作机构 |
开始日期2022-04-08 |
申办/合作机构 |
开始日期2022-03-28 |
申办/合作机构 |